WT1 and chronic myelogenous leukemia, BCR-ABL1 positive: In earlier functional studies, LAA-specific CTL responses to WT1 and PR3 were identified in CML patients and healthy donors, albeit at a lower frequency in the latter, and shown to expand in the recipient after transplantation, contributing to remission (83).